Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dimenhydrinate
Drug ID BADD_D00676
Description Dimehydrinate was first described in the literature in 1949,[A233120] and patented in 1950.[L32995] Early research into dimenhydrinate focused on its role as an antihistamine for urticaria; the treatment of motion sickness was an accidental discovery.[A233130] Dimenhydrinate, also known as B-dimethylaminoethyl benzohydrol ether 8-chlorotheophyllinate, is indicated to prevent nausea, vomiting, and dizziness caused by motion sickness.[L32980,L32985,L32995] Dimenhydrinate is a combination of [Diphenhydramine] and [8-chlorotheophylline] in a salt form, with 53%-55.5% dried diphenhydramine, and 44%-47% died 8-chlorotheophylline.[L32985] The antiemetic properties of dimenhydrinate are primarily thought to be produced by diphenhydramine's antagonism of H1 histamine receptors in the vestibular system[A1540] while the excitatory effects are thought to be produced by 8-chlorotheophylline's adenosine receptor blockade.[A33889] When used in large doses, dimenhydrinate has been shown to cause a "high" characterized by hallucinations, excitement, incoordination, and disorientation.[A1539] Dimenhydrinate was granted FDA approval on 31 May 1972.[L32975]
Indications and Usage Used for treating vertigo, motion sickness, and nausea associated with pregnancy.
Marketing Status Prescription; Discontinued
ATC Code R06AA11
DrugBank ID DB00985
KEGG ID D00520
MeSH ID D004111
PubChem ID 10660
TTD Drug ID D0U8UV
NDC Product Code 12711-4675; 63941-198; 10237-942; 0924-1006; 70000-0404; 11673-198; 63868-034; 10267-1006; 69842-206; 46122-536; 55745-0002; 10237-941; 0363-0198; 29485-6925; 0924-1007; 50804-198; 66715-9809; 49452-2615; 63029-902; 63029-910; 52904-962; 51927-1080; 59779-198; 0904-6772; 36800-930; 49873-802; 0904-2051; 63029-901; 10267-4186; 11822-0198; 10267-4215; 64092-600; 0363-1980; 29485-8048; 63323-366; 10237-940; 50844-199; 49035-981; 29485-1216; 62011-0341; 67751-170; 67091-118; 70677-0022
Synonyms Dimenhydrinate | Diphenhydramine Theoclate | Theoclate, Diphenhydramine | Wehamine | Aviomarin | Biodramina | Calm-X | Calm X | Cinfamar | Contramareo | Dimen Heumann | Heumann, Dimen | Dimen Lichtenstein | Lichtenstein, Dimen | Dimetabs | Dinate | DMH | Dramanate | Gravol | Marmine | Motion-Aid | Motion Aid | Nausicalm | Reisegold | Reisetabletten Lünopharm | Lünopharm, Reisetabletten | Reisetabletten Stada | Stada, Reisetabletten | Reisetabletten-ratiopharm | Reisetabletten ratiopharm | Rodovan | RubieMen | Superpep | Travel Well | TripTone | Vertigo-Vomex | Vertigo Vomex | Vomex A | Vomacur | Vomisin | Dramamine | Apo-Dimenhydrinate | Apo Dimenhydrinate
Chemical Information
Molecular Formula C17H21NO.C7H7ClN4O2
CAS Registry Number 523-87-5
SMILES CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation17.02.05.012; 19.06.02.001--
Dermatitis23.03.04.002--Not Available
Dizziness02.01.02.004; 17.02.05.003; 24.06.02.007--
Dry mouth07.06.01.002--
Dry throat07.06.01.005; 22.02.05.004--Not Available
Dyspepsia07.01.02.001--
Dysuria20.02.02.002--
Fatigue08.01.01.002--
Headache17.14.01.001--
Insomnia17.15.03.002; 19.02.01.002--
Nasal dryness22.04.03.002--Not Available
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Rash23.03.13.001--Not Available
Restlessness17.02.05.021; 19.11.02.002--
Somnolence17.02.04.006; 19.02.05.003--
Tachycardia02.03.02.007--Not Available
Tension19.06.02.005--Not Available
Vision blurred06.02.06.007; 17.17.01.010--
Epigastric discomfort07.01.02.004--Not Available
Decreased appetite08.01.09.028; 14.03.01.005--
Increased bronchial secretion22.02.04.007--Not Available
The 1th Page    1    Total 1 Pages